281 related articles for article (PubMed ID: 32100075)
1. Prostaglandin E
Gierlich P; Lex V; Technau A; Keupp A; Morper L; Glunz A; Sennholz H; Rachor J; Sauer S; Marcu A; Grigoleit GU; Wölfl M; Schlegel PG; Eyrich M
Cancer Immunol Immunother; 2020 Jun; 69(6):1029-1042. PubMed ID: 32100075
[TBL] [Abstract][Full Text] [Related]
2. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
[TBL] [Abstract][Full Text] [Related]
3. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
4. Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28.
Pufnock JS; Cigal M; Rolczynski LS; Andersen-Nissen E; Wolfl M; McElrath MJ; Greenberg PD
Blood; 2011 Jun; 117(24):6542-51. PubMed ID: 21493800
[TBL] [Abstract][Full Text] [Related]
5. Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs.
Rubio MT; Means TK; Chakraverty R; Shaffer J; Fudaba Y; Chittenden M; Luster AD; Sykes M
Int Immunol; 2005 Dec; 17(12):1561-72. PubMed ID: 16303787
[TBL] [Abstract][Full Text] [Related]
6. Addition of CpG ODN and Poly (I:C) to a standard maturation cocktail generates monocyte-derived dendritic cells and induces a potent Th1 polarization with migratory capacity.
Zhu M; Xu W; Su H; Huang Q; Wang B
Hum Vaccin Immunother; 2015; 11(7):1596-605. PubMed ID: 26039883
[TBL] [Abstract][Full Text] [Related]
7. Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells.
Schreibelt G; Benitez-Ribas D; Schuurhuis D; Lambeck AJ; van Hout-Kuijer M; Schaft N; Punt CJ; Figdor CG; Adema GJ; de Vries IJ
Blood; 2010 Jul; 116(4):564-74. PubMed ID: 20424184
[TBL] [Abstract][Full Text] [Related]
8. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
[TBL] [Abstract][Full Text] [Related]
9. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.
Boullart AC; Aarntzen EH; Verdijk P; Jacobs JF; Schuurhuis DH; Benitez-Ribas D; Schreibelt G; van de Rakt MW; Scharenborg NM; de Boer A; Kramer M; Figdor CG; Punt CJ; Adema GJ; de Vries IJ
Cancer Immunol Immunother; 2008 Nov; 57(11):1589-97. PubMed ID: 18322684
[TBL] [Abstract][Full Text] [Related]
10. Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.
Zobywalski A; Javorovic M; Frankenberger B; Pohla H; Kremmer E; Bigalke I; Schendel DJ
J Transl Med; 2007 Apr; 5():18. PubMed ID: 17430585
[TBL] [Abstract][Full Text] [Related]
11. Combined TLR-3/TLR-8 Signaling in the Presence of α-Type-1 Cytokines Represents a Novel and Potent Dendritic Cell Type-1, Anti-Cancer Maturation Protocol.
Fevžer T; Poženel P; Zajc K; Tešić N; Švajger U
Cells; 2022 Feb; 11(5):. PubMed ID: 35269457
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application.
Möller I; Michel K; Frech N; Burger M; Pfeifer D; Frommolt P; Veelken H; Thomas-Kaskel AK
J Immunother; 2008 Jun; 31(5):506-19. PubMed ID: 18463533
[TBL] [Abstract][Full Text] [Related]
13. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
14. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.
Bohnenkamp HR; Coleman J; Burchell JM; Taylor-Papadimitriou J; Noll T
Cell Immunol; 2004; 231(1-2):112-25. PubMed ID: 15919376
[TBL] [Abstract][Full Text] [Related]
15. IL-10 promotes homeostatic proliferation of human CD8(+) memory T cells and, when produced by CD1c(+) DCs, shapes naive CD8(+) T-cell priming.
Nizzoli G; Larghi P; Paroni M; Crosti MC; Moro M; Neddermann P; Caprioli F; Pagani M; De Francesco R; Abrignani S; Geginat J
Eur J Immunol; 2016 Jul; 46(7):1622-32. PubMed ID: 27129615
[TBL] [Abstract][Full Text] [Related]
16. TLR3-Mediated CD8+ Dendritic Cell Activation Is Coupled with Establishment of a Cell-Intrinsic Antiviral State.
Széles L; Meissner F; Dunand-Sauthier I; Thelemann C; Hersch M; Singovski S; Haller S; Gobet F; Fuertes Marraco SA; Mann M; Garcin D; Acha-Orbea H; Reith W
J Immunol; 2015 Aug; 195(3):1025-33. PubMed ID: 26101320
[TBL] [Abstract][Full Text] [Related]
17. Using dendritic cell maturation and IL-12 producing capacity as markers of function: a cautionary tale.
Kaka AS; Foster AE; Weiss HL; Rooney CM; Leen AM
J Immunother; 2008 May; 31(4):359-69. PubMed ID: 18391760
[TBL] [Abstract][Full Text] [Related]
18. Combined TLR stimulation with Pam3Cys and Poly I: C enhances Flt3-ligand dendritic cell activation for tumor immunotherapy.
Lim SN; Kuhn S; Hyde E; Ronchese F
J Immunother; 2012; 35(9):670-9. PubMed ID: 23090076
[TBL] [Abstract][Full Text] [Related]
19. Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+ T-cell cross-priming.
Fehres CM; Bruijns SC; van Beelen AJ; Kalay H; Ambrosini M; Hooijberg E; Unger WW; de Gruijl TD; van Kooyk Y
Eur J Immunol; 2014 Aug; 44(8):2415-24. PubMed ID: 24825342
[TBL] [Abstract][Full Text] [Related]
20. Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells.
Schmitt S; Tahk S; Lohner A; Hänel G; Maiser A; Hauke M; Patel L; Rothe M; Josenhans C; Leonhardt H; Griffioen M; Deiser K; Fenn NC; Hopfner KP; Subklewe M
Front Immunol; 2020; 11():602802. PubMed ID: 33281829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
